Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Clinical benefits reported for local treatment with rHuGM-CSF in skin metastases

July 12, 2002

Selective alphav integrin antagonists in early development at Merck

July 11, 2002

Biovitrum presents novel 5-HT2C ligands for use in obesity and other conditions

July 11, 2002

New data on ezetimibe presented at the EAS congress

July 11, 2002

Potential role of the combination of orlistat and fluvastatin in obesity

July 11, 2002

Enzyme replacement therapy for Fabry's disease to be reviewed by advisory committee

July 10, 2002

Colesevelam improves LDL particle size distribution in moderate hypercholesterolemia

July 10, 2002

Glucagon antagonists or inverse agonists identified at Novo Nordisk and Agouron

July 10, 2002

Synergistic clinical benefits of combination therapy with statins and fibrates

July 9, 2002

Isoxazole compounds and their use in diabetes reported by Takeda

July 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...